TORSELLINI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 280
EU - Europa 201
AS - Asia 108
OC - Oceania 2
Totale 591
Nazione #
US - Stati Uniti d'America 280
CN - Cina 106
IE - Irlanda 67
UA - Ucraina 39
GB - Regno Unito 20
DE - Germania 19
FI - Finlandia 19
IT - Italia 13
BE - Belgio 12
SE - Svezia 11
AU - Australia 2
FR - Francia 1
IN - India 1
IR - Iran 1
Totale 591
Città #
Dublin 66
Chandler 62
Ann Arbor 53
Jacksonville 43
Nanjing 35
Nanchang 18
Woodbridge 14
Hebei 13
Brussels 12
Princeton 12
Lawrence 10
Boardman 9
Medford 8
Ashburn 7
Changsha 7
Jiaxing 7
Shenyang 7
Wilmington 7
Verona 6
Hangzhou 5
Tianjin 5
Des Moines 4
Milan 4
Auburn Hills 2
Beijing 2
Los Angeles 2
Norwalk 2
Shanghai 2
Taizhou 2
Bielefeld 1
Borås 1
Brisbane 1
Caher 1
Changchun 1
Cuneo 1
Fairfield 1
Helsinki 1
Jinan 1
Phoenix 1
Tradate 1
Totale 437
Nome #
Human cytomegalovirus pp67 mRNAemia Vs. pp 65 antigenemia in heart and lung transplant recipients: a prospective randomized controlled open-label trial. 88
Detection and pathogenicity of human metapneumovirus respiratory infections in pediatric Italian patients during a winter-spring season. 79
A comparison of methods for detecting adenovirus type 8 keratoconjunctivitis during a nosocomial outbreak in a Neonatal Intensive Care Unit. 69
Optimized detection of respiratory viruses in nasopharyngeal secretions. 66
In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients. 64
Clinically-based determination of safe DNAemia cutoff levels fo rpreemptive therapy of human cytomegalovirus infections in solid organ and hematopoietic stem cell trasplant recipients 57
Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital 57
Evaluation of cytomegalovirus DNAemia versus pp65-antigenemia cut off for guiding preemptive therapy in transplant recipients: a randomized study 41
Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. 40
Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial 32
Totale 593
Categoria #
all - tutte 1.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 42 56 2 8 2 9 1 9 4 7 4 1
2020/202174 8 8 2 9 1 9 4 10 1 10 11 1
2021/202258 2 3 0 2 3 2 2 3 5 4 7 25
2022/2023191 14 25 4 8 26 17 0 8 79 2 4 4
2023/202429 3 6 0 3 9 4 2 0 0 1 1 0
Totale 593